{"id":"W4385707295","doi":"10.1097/01.hs9.0000970420.62475.d0","title":"P879: LONG-TERM FOLLOW-UP FROM MAJESTEC-1 OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Multiple myeloma; Daratumumab; Cytokine release syndrome; Oncology; Bortezomib; Refractory (planetary science); Gastroenterology; Surgery; Cancer; Clinical trial; Immunotherapy; Chimeric antigen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001449285,0.0003815315,0.0006515894,0.0002788251,0.0001041398,0.00004019947,0.0001992914,0.0002400882,0.0005978851],"category_scores_gemma":[0.0001377067,0.0003025954,0.0001558497,0.0008873714,0.0001239292,0.0002589116,0.0001118697,0.0003705325,0.0004132694],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001911634,"about_ca_system_score_gemma":0.000194049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000528302,"about_ca_topic_score_gemma":0.0009489454,"domain_scores_codex":[0.9970549,0.0001050192,0.000576996,0.0006640239,0.0009453119,0.0006537634],"domain_scores_gemma":[0.9982257,0.000214465,0.0002472833,0.0007833213,0.0002445047,0.0002847094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004661703,0.001229855,0.9696454,0.0003126308,0.0001688954,0.0005770863,0.0003806129,0.000004172569,0.01402189,0.000004032561,0.0007988279,0.008194899],"study_design_scores_gemma":[0.02339902,0.0008250996,0.9647265,0.000648917,0.00005658535,0.000003374666,0.0002357242,0.0001690668,0.009324816,0.00001336163,0.0003277992,0.000269727],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960107,0.0004617136,0.00004672173,0.00006765494,0.0002394271,0.001530712,0.0002192982,0.000158603,0.001265138],"genre_scores_gemma":[0.9934517,0.0002048846,0.000739126,0.00002332419,0.00008454984,0.00006704694,0.002943887,0.00009451175,0.002390949],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01873731,"threshold_uncertainty_score":0.9999426,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01996740738613229,"score_gpt":0.2765928248278406,"score_spread":0.2566254174417083,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}